Study of the Clinical Efficacy and Safety of Finerenone for the Treatment of IGA Nephropathy

NCT06460987 · clinicaltrials.gov ↗

COMPLETED

Status

245

Enrollment

OTHER

Sponsor class

Conditions

Finerenone
IgA Nephropathy
Proteinuria
Safety Issues

Interventions

DRUG: Finerenone
DRUG: RAS inhibitor
DRUG: Immune Suppressant

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine